4-(Methylsulfonyl)phenylacetic Acid CAS 90536-66-6 Maʻemaʻe >99.5% (HPLC) Etoricoxib Intermediate Factory
Ke alakaʻi nei i ka mea hana a me ka mea hoʻolako, nā mea waena o Etoricoxib
Etoricoxib API CAS 202409-33-4
4-(Methylthio)Phenylacetic Acid CAS 16188-55-9
4-(Methylsulfonyl)Phenylacetic Acid CAS 90536-66-6
Please contact: alvin@ruifuchem.com
| Inoa Kimia | 4-(Methylsulfonyl)phenylacetic Acid |
| Nā huaʻōlelo like | 4-Methylsulphonylphenylacetic Acid;4-(Methanesulfonyl)ʻakika phenylacetic;(4-Methanesulfonylphenyl)acetic Acid;4-Methylsulfonyl Phenyl Acetic Acid;2-(4-(Methylsulfonyl)phenyl)acetic Acid;[p-(Methylsulfonyl)phenyl]-Acetic Acid;4-Mesylphenylacetic Acid |
| Helu CAS | 90536-66-6 |
| Helu CAT | RF-PI1182 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
| ʻĀpana Molekala | C9H10O4S |
| Kaumaha Molecular | 214.24 |
| Lae hehee | 136.0 a 140.0 ℃ |
| ʻO ka mānoanoa | 1.35 |
| Ka hoʻoheheʻe | Hiki ke hoʻoheheʻe ʻia i ka Methanol |
| Brand | Kemika Ruifu |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | Keʻokeʻo i ka pauda paʻa keʻokeʻo |
| Maʻemaʻe / Kaʻina Hanana | >99.5% (HPLC) |
| Lae hehee | 136.0 a 140.0 ℃ |
| Māmā (KF) | <0.50% |
| ʻO ka haumia nui loa | <0.30% |
| Huina paumaele | <0.50% |
| Infrared Spectrum | Kūlike i ka hoʻolālā |
| Kūlana hoʻāʻo | ʻOihana Kūlana |
| Hoʻohana | Kūwaena o Etoricoxib (CAS: 202409-33-4) |
Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai
ʻO 4-(Methylsulfonyl)phenylacetic Acid (CAS: 90536-66-6) kahi mea waena o Etoricoxib (CAS: 202409-33-4).ʻO Etoricoxib kahi ʻano o ka cyclooxygenase-2 (COX-2) koho nui i hoʻomohala ʻia e ka hui Merck.Hoʻohana nui ʻia ʻo Etoricoxib i ka mālama ʻana i ka osteoarthritis (OA), rheumatoid arthritis, ankylosing spondylitis, ʻeha haʻahaʻa haʻahaʻa haʻahaʻa, acute gouty arthritis, dysmenorrhea mua a me ka ʻeha postoperative, a me nā maʻi ʻē aʻe.ʻO Etoricoxib, kahi mea hoʻopaneʻe COX-2 koho, loaʻa nā hopena anti-inflammatory, analgesic a me nā antipyretic, kūpono no ka mālama ʻana i nā hōʻailona a me nā hōʻailona o ka osteoarthritis a me ka maʻi maʻi, a me ka maʻi gouty acute.Hoʻopili koke ʻia ʻo Etoricoxib, me ka bioavailability waha o 80 a 100%, a hiki i ka nui o ka plasma concentrations i loko o 1 a 2 mau hola ma hope o ka lawe ʻana.Hoʻemi ka meaʻai i ka nui o ka absorption akā ʻaʻohe hopena i ka nui o ka absorption.Hōʻike ia i ka hapalua o ke ola lōʻihi ma kahi o 22 mau hola, e hōʻike ana i ka pharmacokinetics plasma linear me ka ʻole o ka hōʻiliʻili ʻana i ka wā o ka hoʻohana ʻana.
